AngII promotes insulin resistance, de novo lipogenesis and pro-inflammatory cytokine production, and triggers liver inflammation and fibrogenesis [77], while active Ang (1–7) signal inhibits liver lipogenesis, fatty acid oxidation, inflammation and fibrosis [78,79]. The gene discussed is ANGPT1; the disease is Insulin resistance.